AR058022A1 - DERIVATIVES OF BENZOOXAZOLES, PHARMACEUTICAL COMPOSITIONS AND ITS USE FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS. - Google Patents
DERIVATIVES OF BENZOOXAZOLES, PHARMACEUTICAL COMPOSITIONS AND ITS USE FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS.Info
- Publication number
- AR058022A1 AR058022A1 ARP060103590A AR058022A1 AR 058022 A1 AR058022 A1 AR 058022A1 AR P060103590 A ARP060103590 A AR P060103590A AR 058022 A1 AR058022 A1 AR 058022A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- halogen
- treatment
- mono
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
En realizaciones de la misma, compuestos específicos descriptos en la presente son utilizados para la fabricacion de un medicamento util en el tratamiento de desordenes del SNC, en particular el tratamiento de desordenes de ansiedad, incluyendo desorden de ansiedad generalizada y desorden de pánico, desorden obsesivo compulsivo, agresion, adiccion (incluyendo ansia), depresion, autismo, vértigo, esquizofrenia y otros desordenes psicoticos, enfermedad de Parkinson y disturbios del conocimiento y memoria. Métodos para su preparacion y composiciones farmacéuticas que los comprenden. Reivindicacion 1: Derivados de piperazina y piperidina de la formula general (1) en donde R1 es hidrogeno, halogeno alquilo C1-3, CN, CF3, OCF3, SCF3, alcoxi C1-3, amino o mono- o dialquil C1-3 sustituido amino, o hidroxi; ---Z representa =C o -N; R2 es hidrogeno o alquilo C1-3; R3 y R4 independientemente representan H o alquilo C1-3, o R3 y R4 juntos puede formar un puente de 2 o 3 átomos de carbono; Q es metilo, etilo o ciclopropilmetilo los cuales grupos etilo o ciclopropilmetilo están opcionalmente sustituidos con uno o más átomos de fluor, o Q es bencilo o 2-, 3- o 4-piridilmetilo, los cuales grupos están opcionalmente sustituidos con uno o más sustituyentes del grupo halogeno, nitro, ciano, amino, mono- o dialquil C1-3amino, alcoxi C1-3, CF3, OCF3, SCF3, alquilo C1-3, alquil C1-3sulfonilo o hidroxilo, o Q es un grupo de la formula (2) en donde R5 es halogeno, hidroxi, alcoxi C1-3 o alquilo C1-3; y q es 0, 1, 2 o 3; Y es fenilo, furanilo o tienilo, los cuales pueden estar sustituidos con 1-3 sustituyentes del grupo hidroxi, halogeno, alcoxi C1-3, alquilo C1-3, ciano, aminocarbonilo, mono- o dialquil C1- 3aminocarbonilo; y tautomeros, estereoisomeros, sales, hidratos y solvatos de los mismos farmacologicamente aceptables.In embodiments thereof, specific compounds described herein are used for the manufacture of a medicament useful in the treatment of CNS disorders, in particular the treatment of anxiety disorders, including generalized anxiety disorder and panic disorder, obsessive disorder. compulsive, aggression, addiction (including craving), depression, autism, vertigo, schizophrenia and other psychotic disorders, Parkinson's disease and disturbances of knowledge and memory. Methods for their preparation and pharmaceutical compositions that comprise them. Claim 1: Piperazine and piperidine derivatives of the general formula (1) wherein R1 is hydrogen, halogen C1-3 alkyl, CN, CF3, OCF3, SCF3, C1-3 alkoxy, amino or mono- or substituted C1-3 dialkyl amino, or hydroxy; --- Z represents = C or -N; R2 is hydrogen or C1-3 alkyl; R3 and R4 independently represent H or C1-3 alkyl, or R3 and R4 together can form a bridge of 2 or 3 carbon atoms; Q is methyl, ethyl or cyclopropylmethyl which ethyl or cyclopropylmethyl groups are optionally substituted with one or more fluorine atoms, or Q is benzyl or 2-, 3- or 4-pyridylmethyl, which groups are optionally substituted with one or more substituents of the halogen, nitro, cyano, amino, mono- or dialkyl C1-3amino, C1-3 alkoxy, CF3, OCF3, SCF3, C1-3 alkyl, C1-3 alkyl sulfonyl or hydroxyl group, or Q is a group of the formula ( 2) wherein R5 is halogen, hydroxy, C1-3 alkoxy or C1-3 alkyl; and q is 0, 1, 2 or 3; Y is phenyl, furanyl or thienyl, which may be substituted with 1-3 substituents of the hydroxy, halogen, C1-3 alkoxy, C1-3 alkyl, cyano, aminocarbonyl, mono- or C1-3-dialkylcarbonyl group; and pharmacologically acceptable tautomers, stereoisomers, salts, hydrates and solvates thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05107671 | 2005-08-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR058022A1 true AR058022A1 (en) | 2008-01-23 |
Family
ID=35502590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060103590 AR058022A1 (en) | 2005-08-22 | 2006-08-17 | DERIVATIVES OF BENZOOXAZOLES, PHARMACEUTICAL COMPOSITIONS AND ITS USE FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS. |
Country Status (7)
Country | Link |
---|---|
CN (1) | CN101248053B (en) |
AR (1) | AR058022A1 (en) |
BR (1) | BRPI0614843A2 (en) |
HK (1) | HK1120261A1 (en) |
TW (1) | TW200738656A (en) |
UA (1) | UA94718C2 (en) |
ZA (1) | ZA200800741B (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE503170A (en) * | 1975-09-02 | |||
PL189256B1 (en) * | 1996-03-29 | 2005-07-29 | Duphar Int Res | Chemical compounds of piperazine and piperidine |
UA71590C2 (en) * | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
ATE255578T1 (en) * | 2000-05-12 | 2003-12-15 | Solvay Pharm Bv | PIPERAZINE AND PIPERIDINE COMPOUNDS |
NZ533041A (en) * | 2002-01-16 | 2006-04-28 | Janssen Pharmaceutica Nv | Prucalopride-N-oxide |
-
2006
- 2006-08-17 AR ARP060103590 patent/AR058022A1/en not_active Application Discontinuation
- 2006-08-18 TW TW095130407A patent/TW200738656A/en unknown
- 2006-08-21 UA UAA200803586A patent/UA94718C2/en unknown
- 2006-08-21 CN CN2006800306608A patent/CN101248053B/en not_active Expired - Fee Related
- 2006-08-21 BR BRPI0614843-3A patent/BRPI0614843A2/en not_active IP Right Cessation
-
2008
- 2008-01-24 ZA ZA200800741A patent/ZA200800741B/en unknown
- 2008-11-06 HK HK08112134.4A patent/HK1120261A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA200800741B (en) | 2009-01-28 |
CN101248053A (en) | 2008-08-20 |
HK1120261A1 (en) | 2009-03-27 |
BRPI0614843A2 (en) | 2012-12-04 |
TW200738656A (en) | 2007-10-16 |
UA94718C2 (en) | 2011-06-10 |
CN101248053B (en) | 2011-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR062209A1 (en) | MGLUR5 METABOTROPIC GLUTAMATE RECEPTORS MODULATING PIRAZOLOPIRIMIDINES, PROCESS FOR PREPARATION, MEDICATIONS CONTAINING THEM AND USES IN THE PREVENTION AND / OR TREATMENT OF ACUTE AND CHRONIC NEUROLOGICAL DISORDERS. | |
AR066460A2 (en) | COMPOUNDS DERIVED FROM PHENYL-PIPERAZINE, PHENYL-PIPERIDINE AND PHENYL-TETRAHIDROPIRIDINE AS INHIBITORS OF THE REABSORTION OF SEROTONIN, A PHARMACEUTICAL COMPOSITION AND USE OF THE SAME FOR THE PREPARATION OF MEDICINES | |
TW200720266A (en) | Benzodioxane and benzodioxolan derivatives and uses thereof | |
AR049739A1 (en) | ARIL-PYRIDINE DERIVATIVES | |
AR049276A1 (en) | OPIOOD CARBOXAMID COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
NO20053960L (en) | Piperidine-benzenesulfonamide | |
AR052156A1 (en) | FENIL-METANONAS BI- AND SUBSTITUTED TRICYCLES FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | |
RS54260B1 (en) | Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
AR035722A1 (en) | DERIVATIVES OF INDOL, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF SUCH COMPOUNDS FOR THE PRODUCTION OF MEDICINES | |
RS51471B (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
PE20080277A1 (en) | SPYROCYCLIC AND SUBSTITUTED AZAINDOL DERIVATIVES | |
MEP22008A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
BRPI0513281A (en) | compound or compounds, medicaments, use of at least one compound, method for the therapeutic and / or prophylactic treatment of a mammal, and process for producing a compound | |
ATE469885T1 (en) | NEW DISUBSTITUTED PHENYLPIPERIDINE AND PIPERAZINE AS MODULATORS OF DOPAMINE NEUROTRANSMISSION | |
PE20030416A1 (en) | 1,8-NAFTIRIDIN-4 (1H) -ONAS ALQUIN ARIL SUBSTITUTED AS INHIBITORS OF PHOSPHODIESTERASE-4 | |
AR069796A1 (en) | DERIVATIVES OF BENCIMIDAZOL, REPLACED BY CARBOXYL OR HYDROXYL, PROCESS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
WO2005080357A3 (en) | Oxazole derivatives, preparation and therapeutic use therof | |
NO20063597L (en) | Acetylinic piperazine compounds and their use as metabotrophic glutamate receptor antagonists | |
EA201170098A1 (en) | SUBSTITUTED DERIVATIVES ALKYLPYRIMIDIN-4-SHE | |
AR050711A1 (en) | ARILSULFONYLESTILBEN DERIVATIVES FOR THE TREATMENT AND / OR PREVENTION OF AFFECTIONS OF THE CENTRAL NERVOUS SYSTEM | |
PE20080345A1 (en) | PIPERAZINE DERIVATIVES AS AGONISTS OF THE GPR38 RECEPTOR | |
NO20081435L (en) | N-oxides as prodrugs for piperazine and piperidine derivatives | |
AR038483A1 (en) | DERIVATIVES OF QUINAZOLINONA, A PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AS CANABINOID AGONISTS | |
ECSP088257A (en) | AMIDA DERIVATIVES | |
MX2009012383A (en) | Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |